|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,435.00 JPY | +1.52% |
|
+0.39% | +12.08% |
| Market Cap | 1,144B 6.99B 6.14B 5.71B 5.24B 9.84B 673B 10B 67.8B 26.49B 331B 26.24B 25.67B | P/E 2027 * |
16.1x | P/E 2028 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 945B 5.77B 5.07B 4.72B 4.33B 8.13B 556B 8.26B 55.99B 21.88B 273B 21.67B 21.2B | EV / Sales 2027 * |
2.08x | EV / Sales 2028 * | 2.08x |
| Free-Float |
80.98% | Yield 2027 * |
3.22% | Yield 2028 * | 3.18% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +1.52% | ||
| 1 week | +0.39% | ||
| Current month | +1.97% | ||
| 1 month | +3.62% | ||
| 3 months | +3.62% | ||
| 6 months | +6.45% | ||
| Current year | +12.08% |
| 1 week | 2,378 |  | 2,448.5 |
| 1 month | 2,326 | | 2,507 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Shusaku Nagae
BRD | Director/Board Member | 76 | 2021-05-31 |
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Masao Nomura
BRD | Director/Board Member | 76 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | +0.39% | +48.79% | -5.82% | 6.99B | |
| -0.66% | +0.44% | +14.72% | +76.40% | 48.36B | |
| +2.20% | +1.41% | +61.04% | +111.43% | 35.8B | |
| +1.26% | -0.57% | -5.20% | +34.48% | 11.83B | |
| -0.46% | -3.06% | +14.15% | +80.63% | 11.48B | |
| -0.37% | -0.37% | +37.89% | +137.78% | 9.01B | |
| -0.17% | -2.92% | +13.13% | +30.45% | 6.7B | |
| -0.59% | -1.95% | +2.23% | +178.07% | 6.42B | |
| -7.92% | -13.61% | -34.97% | -4.08% | 5.3B | |
| -2.05% | -1.46% | +20.49% | +136.46% | 4.37B | |
| Average | -0.72% | -2.05% | +17.23% | +77.58% | 14.63B | |
| Weighted average by Cap. | +0.05% | -0.48% | +25.21% | +83.01% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 454B 2.78B 2.44B 2.27B 2.08B 3.91B 267B 3.97B 26.92B 10.52B 131B 10.42B 10.19B | 444B 2.72B 2.38B 2.22B 2.04B 3.82B 261B 3.88B 26.34B 10.29B 129B 10.19B 9.97B |
| Net income | 70.98B 434M 381M 354M 325M 611M 41.76B 620M 4.21B 1.64B 20.53B 1.63B 1.59B | 62.51B 382M 335M 312M 286M 538M 36.78B 546M 3.7B 1.45B 18.08B 1.43B 1.4B |
| Net Debt | -199B -1.22B -1.07B -994M -912M -1.71B -117B -1.74B -11.8B -4.61B -57.62B -4.57B -4.47B | -218B -1.33B -1.17B -1.09B -999M -1.88B -128B -1.91B -12.93B -5.05B -63.12B -5B -4.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | JP¥2,435.00 | +1.52% | 1,507,300 |
| 26-07-23 | JP¥2,398.50 | -0.27% | 1,081,400 |
| 26-07-22 | JP¥2,405.00 | +0.33% | 1,236,400 |
| 26-07-21 | JP¥2,397.00 | -1.18% | 1,492,300 |
| 26-07-17 | JP¥2,425.50 | +3.37% | 2,057,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
